Pain, the Opioid Epidemic, and Depression

Inbunden, Engelska, 2024

AvJeffrey F. Scherrer,Jane C. Ballantyne

1 229 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Long-term prescription opioid use occurs in a substantial proportion of new opioid users. Most concerning is that high risk patients with comorbid depression, anxiety, nicotine dependence, and substance use disorders, compared to patients without these factors, continue to be prescribed higher opioid doses for longer durations, and are more likely to receive opioids with high abuse potential. To understand this phenomenon, we must consider the relationships between pain, mental illness, substance use disorder and long-term prescription opioid use. While separate fields have investigated the bi-directional relationships between depression, pain, and long-term prescription opioid use independently of one another, there is no text which has brought together the complex interaction of all three together. Drawing on contributions from neuroscience, pain psychiatry, clinical epidemiology, pharmacoepidemiology, clinical trials and research on social determinants of health, Pain, the Opioid Epidemic, and Depression is the first book to integrate currently siloed areas of investigation and clinical knowledge. This book takes a comprehensive approach, from neurophysiology to epidemiology to clinical practice, and explains the processes driving maintenance of chronic pain, persistent depression, and long-term prescription opioid use, as well as taper and buprenorphine treatment for opioid use disorder. Readers will come to understand the central role of depression, other psychiatric disorders, and social determinants that contribute to pain management outcomes, the opioid epidemic, and our response to opioid dependence and opioid use disorder. By taking a multidisciplinary approach to compiling what is known about the relationships between pain, depression, other psychiatric disorders and opioids, this volume will be a valuable clinical resource for a range of healthcare and mental health professionals who encounter chronic pain and comorbid mood disorders, while also spawning new directions for researchers.

Produktinformation

Utgivningsdatum2024-12-19
Mått165 x 249 x 22 mm
Vikt454 g
FormatInbunden
SpråkEngelska
Antal sidor200
FörlagOUP USA
ISBN9780197675229

Tillhör följande kategorier

Missbruk inom Medicin
Folkhälsa och hälsopedagogik inom Medicin

Jeffrey F. Scherrer PhD is Vice-Chair for Research and Professor in the Department of Family and Community Medicine and dually appointed Professor in the Department of Psychiatry and Behanioral Neuroscience at Saint Louis Univeristy School of Medicine, Missouri, US. He received his doctoral degree in health services research. He began his academic career at Washington University in St. Louis focusing on twin studies of substance use disorder and comorbid mental illness. He transferred to Saint Louis University in 2013 and has since devoted considerable time to researching mental and psychosocial outcomes following long-term prescription opioid use. His approach is grounded in observational cohort studies using both retrospective medical record and medical claims data and prospective cohort designs to better understand the inter-relationships between pain, prescription opioid use and misuse and psychiatric disorders. Jane C. Ballantyne MD FRCA is Professor of Anesthesiology and Pain Medicine at the Univerity of Washington, Seattle, Washington, US. She trained in medicine and anaesthesia in the UK before moving to Boston, MA in 1990. She became Chief of the Division of Pain Medicine in the Massachusetts General Hospital in 1999. She moved to the University of Washington in 2011 as Professor of Anesthesiology and Pain Medicine. She has editorialroles in several leading journals and textbooks and is a widely published author. She was an early advocate for restraint in opioid prescribing for chronic pain, and has continued to focus her teaching and research on the clinical implications of evolving opioid science.

Chapter 1: Jeffrey F. Scherrer and Jane C. Ballantyne: Overview and Purpose Chapter 2: Geoffrey Panjeton and Hess Amir Panjeton: Neurophysiology of Pain, Depression, and Exogenous Opioids Chapter 3: Mark D. Sullivan: Looking Beyond Tissue Damage: Pain as a Homeostatic Emotion Chapter 4: Jeffrey F. Scherrer and Joanne Salas: Prescription Opioid Use and Risk of Depression and Worsening Mental Health Chapter 5: Lisa R. Miller-Matero: Depression and Pain: Bidirectional Relationship and Changes with Psychological Treatment Chapter 6: Matthew J. Bair and Ashli A. Owen-Smith: Other Psychiatric Disorders, Psychosocial Factors, Sleep, and Pain Chapter 7: Fred Rottnek and Jennifer Bello-Kottenstette: The Impact of Social and Structural Determinants on Depression, Prescription Opioid Use, Opioid Misuse, and Opioid Use Disorder Chapter 8: Travis I. Lovejoy and Belle Zaccari: Opioid Taper and Complex Prescription Opioid Dependence: The Role of Depression Chapter 9: Ajay Manhapra, Robert Rosenheck and William C. Becker: Potential Role for Buprenorphine in the Management of Comorbid Depression Among People with Chronic Pain and Long-Term Opioid Therapy Dependence Chapter 10: Jane C. Ballantyne, Mark D. Sullivan and Jeffrey F. Scherrer: Future Directions in Pain Management: Implications for Depression and Mental Health

For pain scientists, clinicians and trainees, I suggest reading, Pain, the Opioid Epidemic, & Depression, ... The assembled authors' pain, addiction and depression expertise are both evident and quite up-to-date. It's a remarkably well-organized textbook, where any topic overlap is intentional, not redundant. ... For me this comprehensively yet brief textbook is a worthwhile read for our students, our trainees and for ourselves.